Wagner Bowman Management Corp bought a new position in shares of Becton Dickinson and Co. (NYSE:BDX) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,505 shares of the company’s stock, valued at approximately $255,000.

Other large investors have also modified their holdings of the company. BlackRock Fund Advisors boosted its stake in shares of Becton Dickinson and by 9.5% in the first quarter. BlackRock Fund Advisors now owns 3,911,925 shares of the company’s stock worth $593,908,000 after buying an additional 340,497 shares during the period. Franklin Resources Inc. boosted its stake in shares of Becton Dickinson and by 0.6% in the first quarter. Franklin Resources Inc. now owns 3,837,384 shares of the company’s stock worth $582,591,000 after buying an additional 22,692 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Becton Dickinson and by 20.4% in the first quarter. JPMorgan Chase & Co. now owns 2,300,833 shares of the company’s stock worth $349,312,000 after buying an additional 389,262 shares during the period. Geode Capital Management LLC boosted its stake in shares of Becton Dickinson and by 1.7% in the first quarter. Geode Capital Management LLC now owns 1,683,773 shares of the company’s stock worth $255,101,000 after buying an additional 28,707 shares during the period. Finally, Fundsmith LLP boosted its stake in shares of Becton Dickinson and by 2.0% in the first quarter. Fundsmith LLP now owns 1,614,464 shares of the company’s stock worth $245,108,000 after buying an additional 31,600 shares during the period. Institutional investors and hedge funds own 81.96% of the company’s stock.

Shares of Becton Dickinson and Co. (NYSE:BDX) traded up 1.98% on Wednesday, reaching $179.38. 767,907 shares of the company were exchanged. Becton Dickinson and Co. has a 1-year low of $128.87 and a 1-year high of $179.62. The company has a 50-day moving average price of $174.96 and a 200 day moving average price of $166.51. The stock has a market capitalization of $38.19 billion, a PE ratio of 34.23 and a beta of 0.97.

Becton Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, August 4th. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.14. Becton Dickinson and had a net margin of 9.24% and a return on equity of 24.26%. The firm earned $3.20 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same quarter in the previous year, the company posted $2.05 EPS. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, analysts forecast that Becton Dickinson and Co. will post $8.57 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Friday, September 9th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend is Wednesday, September 7th. Becton Dickinson and’s payout ratio is 50.19%.

Several equities research analysts recently issued reports on the stock. Leerink Swann restated a “hold” rating on shares of Becton Dickinson and in a research report on Tuesday, August 9th. Cowen and Company restated an “outperform” rating and set a $185.00 price objective on shares of Becton Dickinson and in a research report on Tuesday, August 16th. Argus restated a “buy” rating on shares of Becton Dickinson and in a research report on Sunday, June 12th. Evercore ISI cut shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday, June 1st. Finally, Jefferies Group raised their price objective on shares of Becton Dickinson and from $190.00 to $192.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. Eight research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Becton Dickinson and currently has an average rating of “Buy” and a consensus price target of $169.46.

In related news, insider Linda M. Tharby sold 11,704 shares of the business’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares of the company’s stock, valued at approximately $3,925,821.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary M. Cohen sold 29,367 shares of the business’s stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $176.81, for a total transaction of $5,192,379.27. Following the completion of the transaction, the insider now directly owns 125,870 shares of the company’s stock, valued at approximately $22,255,074.70. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).

Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.